Effect of N-acetylcysteine treatment on the expression of leukocyte surface markers after burn injury

Burns

Volumn 37, Issue 3, 2011, Pages 453-464

  Csontos, C ^a   Rezman, B ^a   Foldi, V ^a   Bogar, L ^a   Bognar, Z ^a   Drenkovics, L ^a   Roth E ^a   Weber, G ^a   Lantos, J ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Burn injury; Leukocyte cell surface markers; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; ALPHA4 INTEGRIN; CD11B ANTIGEN; HYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY SURFACE; BURN; CLINICAL ARTICLE; FEMALE; GRANULOCYTE FUNCTION; HOSPITAL ADMISSION; HUMAN; MALE; MEDICAL RECORD; PROTEIN EXPRESSION;

ACETYLCYSTEINE; AGED; ANTIGENS, CD; ANTIOXIDANTS; BIOLOGICAL MARKERS; BURNS; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; OXIDATIVE STRESS; PROSPECTIVE STUDIES;

EID: 79952700323     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2010.10.008     Document Type: Article

References (65)

1. Demling RH. The burn edema process: current concepts. J Burn Care Rehab 2005;26:207-27. (Pubitemid 40733861)
2. American Burn Association Evidence-Based Guidelines Group. Practice guidelines for burn care. J Burn Care Rehab 2001;22:27-52.
3. Holm C, Melcer B, Hörbrand F, Wörl H, von Donnersmarck GH, Mühlbauer W. Intrathoracic blood volume as an end point in resuscitation of the severely burned: an observational study of 24 patients. J Trauma 2000;48:728-34. (Pubitemid 30214907)
4. Holm C, Mayr M, Tegeler J, Hörbrand F, Henckel von Donnersmarck G, Mühlbauer W, et al. A clinical randomized study on the effects of invasive monitoring on burn shock resuscitation. Burns 2004;30:798-807. (Pubitemid 39536046)
5. Csontos C, Foldi V, Fischer T, Bogar L. Arterial thermodilution in burn patients suggest a more rapid fluid administration during early resuscitation. Acta Anaesthesiol Scand 2008;52:742-9.
6. Foldi V, Csontos C, Bogar L, Roth E, Lantos J. Effects of fluid resuscitation methods on burn trauma induced oxidative stress. J Burn Care Rehab 2009;30:957-66.
7. Foldi V, Lantos J, Bogar L, Roth E, Weber G, Csontos C. Effects of fluid resuscitation methods on the pro- and antiinflammatory cytokines and expression of adhesion molecules after burn injury. J Burn Care Rehab 2010;31:480-91.
8. Küntscher MV, Germann G, Hartmann B. Correlation between cardiac output, stroke volume, central venous pressure, intra-abdominal pressure and total circulating blood volume in resuscitation of major burns. Resuscitation 2006;70:37-43. (Pubitemid 43922391)
9. Guang-Yi W, Bing M, Hong-Tai T, Shi-Hui Z, Jian L, Wei W, et al. Esophageal echo-Doppler monitoring in burn shock resuscitation: are hemodynamic variables the critical standard guiding fluid therapy? J Trauma-Injury Infect Crit Care 2008;65:1396-401.
10. Oda J, Yamashita K, Inoue T, Harunari N, Ode Y, Mega K, et al. Resuscitation fluid volume and abdominal compartment syndrome in patients with major burns. Burns 2006;32:151-4. (Pubitemid 43197649)
11. Dubick MA, Williams C, Geir I, Elgjo, Kramer GC. High-dose vitamin C infusion reduces fluid requirements in the resuscitation of burn-injured sheep. Shock 2005;24:139-44. (Pubitemid 41105511)
12. Tanaka H, Matsuda T, Miyagantani Y, Yukioka T, Matsuda H, Shimazaki S. Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration. Arch Surg 2000;135:326-31. (Pubitemid 30154575)
13. Berger MM, Chioléro RL. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 2007;35:584-90.
14. Konukoglu D, Cetinkale O, Bulan R. Effects of N-acetylcisteine on lung gluthathione levels in rats after thermal injury. Burns 1997;23:541-4. (Pubitemid 28142374)
15. Cetinkale O, Senel O, Bulan R. The effect of antioxidant therapy on cell-mediated immunity following burn injury in an animal model. Burns 1999;25:113-8. (Pubitemid 29134665)
16. Ocal K, Avlan D, Cinel I, Unlu A, Ozturk C, Yaylak F, et al. The effect of N-acetylcysteine on oxidative stress in intestine and bacterial translocation after thermal injury. Burns 2004;30:778-84. (Pubitemid 39536043)
17. Turut H, Ciralik H, Kilinc M, Ozbag D, Imrek SS. Effects of early administration of dexamethasone, N-acetylcysteine and aprotinin on inflammatory and oxidant - antioxidant status after lung contusion in rats. Injury Int J Care Injured 2009;40:521-7.
18. Geudens N, Wuyts WA, Rega FR, Vanaudenaerde BM, Neyrinck AP, Verleden GM, et al. N-acetyl cysteine attenuates the inflammatory response in warm ischemic pig lungs. J Surg Res 2008;146:177-83. (Pubitemid 351484135)
19. Jin X, Wang L, Wu H-S, Zhang L, Wang C-Y, Tian Y, et al. N-acetylcysteine inhibits activation of toll-like receptor 2 and 4 gene expression in the liver and lung after partial hepatic ischemia-reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 2007;6:284-9. (Pubitemid 46925250)
20. Gundersen Y, Vaagenes P, Thrane I, Sterri SH, Opstad PK. N-acetylcysteine administered as part of the immediate post-traumatic resuscitation regimen does not significantly influence initiation of inflammatory responses or subsequent endotoxin hyporesponsiveness. Resuscitation 2005;64:377-82. (Pubitemid 40298795)
21. Oroszlán M, Bieri M, Ligeti N, Farkas A, Koestner SC, Meier B, et al. Proliferation signal inhibitor-induced decrease of vascular endothelial cadherin expression and increase of endothelial permeability in vitro are prevented by an antioxidant. J Heart Lung Transplant 2008;27:1311-8.
22. Radomska DM, Niewska LE, Sadowska AM, Van Overveld FJ, Demkow U, Zieliñski J, et al. Influence of N-acetylcysteine on ICAM-1 expression and IL-8 release from endothelial and epithelial cells. J Physiol Pharmacol 2006;57:325-34. (Pubitemid 44638216)
23. Dauletbaev N, Fischer P, Aulbach B, Gross J, Kusche W, Thyroff-Friesinger U, et al. A phase II study on safety and efficacy of high-dose n-acetylcysteine in patients with cystic fibrosis. Eur J Med Res 2009;14:352-8.
24. Miller AC, Rivero A, Ziad S, Smith DJ, Elamin EM. Influence of nebulized unfractionated heparin and N-acetylcysteine in acute lung injury after smoke inhalation injury. J Burn Care Res 2009;30:249-56.
25. Karen EA, Michael WA, Novick RJ, Fox SA, Gallo K, Martin CM, et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery. JAMA 2005;294:342-50. (Pubitemid 41043778)
26. Sayeed MM. Inflammatory/cardiovascular-metabolic responses in a rat model of burn injury with superimposed infection. Shock 2005;24:40-4.
27. Nwariaku F, Sikes PJ, Lightfoot Jr E, Mileski WJ. Inhibition of selectin- and integrin-mediated inflammatory response after burn injury. J Surg Res 1996;63:355-8. (Pubitemid 26197220)
28. Rodeberg DA, Bass RC, Alexander JW, Warden GD, Babcock GF. Neutrophils from burn patients are unable to increase the expression of CD11b/CD18 in response to inflammatory stimuli. J Leukoc Biol 1997;61:575-82. (Pubitemid 27234454)
29. Choi M, Rabb H, Arnaout MA, Ehrlich HP. Preventing the infiltration of leukocytes by monoclonal antibody blocks the development of progressive ischemia in rat burns. Plast Reconstr Surg 1995;96:1177-87.
30. Borsiczky B, Fodor B, Rácz B, Gasz B, Jeges S, Jancsó G, et al. Rapid leukocyte activation following intraarticular bleeding. J Orthop Res 2006;24:684-9. (Pubitemid 43804962)
31. Penberthy TW, Jiang Y, Graves DT. Leukocyte adhesion molecules. Crit Rev Oral Biol Med 1997;8:380-8. (Pubitemid 28123814)
32. Schwacha MG, Chaudry IH, Alexander M. Regulation of macrophage IL-10 production postinjury via beta2 integrin signaling and the P38 MAP kinase pathway. Shock 2003;20:529-35.
33. Steinstraesser L, Alarcon W, Fan MH, Klein RD, Aminlari A, Zuccaro C, et al. Thermal injury induces expression of CD14 in humans. Burns 2002;28:223-30. (Pubitemid 34462065)
34. Yang HM, Yu Y, Chai JK, Hu S, Sheng ZY, Yao YM. Low HLADR expression on CD14+ monocytes of burn victims with sepsis, and the effect of carbachol in vitro. Burns 2008;34:1158-62.
35. Fang WH, Yao YM, Shi ZG, Yu Y, Wu Y, Lu LR, et al. Effect of recombinant bactericidal/permeability-increasing protein on endotoxin translocation and lipopolysaccharide-binding protein/CD14 expression in rats after thermal injury. Crit Care Med 2001;29:1452-9. (Pubitemid 32641811)
36. Eichler W. CD97 isoform expression in leukocytes. J Leukoc Biol 2000;68:561-7.
37. Van Pel M, Hagoort H, Kwakkenbos MJ, Hamann J, Fibbe WE. Differential role of CD97 in interleukin-8-induced and granulocyte-colony stimulating factor-induced hematopoietic stem and progenitor cell mobilization. Haematologica 2008;93:601-4. (Pubitemid 351536390)
38. Molnar Z, Szakmany T, Koszegi T. Prophylactic Nacetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial. Intensive Care Med 2003;29:749-55.
39. Molnár Z, Shearer E, Lowe D. N-acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study. Crit Care Med 1999;27:1100-4. (Pubitemid 29314318)
40. Molnar Z, MacKinnon KL, Shearer E, Lowe D, Watson ID. The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients. Intensive Care Med 1998;24:230-5. (Pubitemid 28190814)
41. Marshall JC, Cook DJ, Christou NV, Bernard GR, Srung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:1638-52.
42. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Int Care Med 1996;22:707-10. (Pubitemid 26254283)
43. Mü hl D, Fü redi R, Cristofari J, Ghosh S, Bogár L, Borsiczki B, et al. Evaluation of oxidative stress in the thrombolysis of pulmonary embolism. J Thromb Thrombolys 2006;22:221-8.
44. Puri KD, Doggett TA, Douangpanya J, Hou Y, Tino WT, Wilson T, et al. Mechanisms and implications of phosphoinositide 3-kinase d in promoting neutrophil trafficking into inflamed tissue. Blood 2004;103:3448-56. (Pubitemid 38525677)
45. Nakae H, Endo S, Yamada Y, Inada K. Bound and soluble adhesion molecule and cytokine levels in patients with severe burns. Burns 2000;26:139-44. (Pubitemid 30050606)
46. Jin RB, Zhu PF, Wang ZG, Liu DW, Zhou JH. Changes of pulmonary intercellular adhesion molecule-1 and CD11b/CD18 in peripheral polymorphonuclear neutrophils and their significance at the early stage of burns. Chin J Traumatol 2003;6:156-9.
47. Cho K, Pham TN, Crivello SD, Jeong J, Green TL, Greenhalgh DG. Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury. Shock 2004;21:144-50.
48. David A, Robert C, AIexander JW, Glenn D, George F. Neutrophils from burn patients are unable to increase the expression of CD11b/CD18 in response to inflammatory stimuli. J Leukoc Blot 1997;61:575-82.
49. Ridger VC, Wagner BE, Wallace WA, Hellewell PG. Differential effects of CD18, CD29, and CD49 integrin subunit inhibition on neutrophil migration in pulmonary inflammation. J Immunol 2001;166:3484-90. (Pubitemid 33117352)
50. Carracedo J, Ramirez R, Maduen JA, Soriano S, Rodriguez-Benot A, Rodriguez M, et al. Cell apoptosis and hemodialysis-induced inflammation. Kidney Int 2002;61:89-93.
51. Jordan J, Beneke R, Haztler M, Veith A, Haller H, Luft FC. Moderate exercise leads to decreased expression of beta1 and beta2 integrins on leucocytes. Eur J Appl Physiol Occup Physiol 1997;76:192-4. (Pubitemid 27359291)
52. Haller H, Ziegler EM, Homuth V, Drab M, Eichhorn J, Nagy Z, et al. Endothelial adhesion molecules and leukocyte integrins in preeclamptic patients. Hypertension 1997;29:291-6. (Pubitemid 27074058)
53. Aziz KE, Wakefield D. In vivo and in vitro expression of adhesion molecules by peripheral blood lymphocytes from patients with primary Sjogren's syndrome: culture-associated enhancement of LECAM-1 and CD44. Rheumatol Int 1995;15:69-74.
54. Puig-Kröger A, Sanz-Rodríguez F, Longo N, Sánchez-Mateos P, Botella L, Teixidó J, et al. Maturation-dependent expression and function of the CD49d integrin on monocyte-derived human dendritic cells. J Immunol 2000;165:4338-45.
55. Wang T, Tian L, Haino M, Gao JL, Lake R, Ward Y, et al. Improved antibacterial host defense and altered peripheral granulocyte homeostasis in mice lacking the adhesion class G protein receptor CD97. Infect Immun 2007;75:1144-53. (Pubitemid 46385805)
56. Eichler W, Hamann J, Aust G. Expression characteristics of the human CD97 antigen. Tissue Antigens 1997;50:429-38. (Pubitemid 27458264)
57. Pel M, Hagoort H, Kwakkenbos MJ, Hamann J, Fibbe WE. Differential role of CD97 in interleukin-8-induced and granulocyte-colony stimulating factor-induced hematopoietic stem and progenitor cell mobilization. Haematologica 2008;93:601-4. (Pubitemid 351536390)
58. Veninga H, Becker S, Hoek RM, Wobus M, Wandel E, van der Kaa J, et al. Analysis of CD97 expression and manipulation: antibody treatment but not gene targeting curtails granulocyte migration. J Immunol 2008;181:6574-83.
59. Kop EN, Adriaansen J, Smeets TJ, Vervoordeldonk MJ, van Lier RA, Hamann J, et al. CD97 neutralisation increases resistance to collagen-induced arthritis in mice. Arthritis Res Ther 2006;8:155.
60. Gasz B, Lenard L, Benko L, Borsiczky B, Szanto Z, Lantos J, et al. Expression of CD97 and adhesion molecules on circulating leukocytes in patients undergoing coronary artery bypass surgery. Eur Surg Res 2005;37:281-9. (Pubitemid 41832681)
61. Barber RC, Aragaki CC, Chang LYE, Purdue GF, Hunt JL, Arnoldo BD, et al. CD14-159 C allele is associated with increased risk of mortality after burn injury. Shock 2007;27:232-7.
62. Finnerty C, Herndon DN, Chinkes DL, Jeschke MG. Serum cytokine differences in severely burned children with and without sepsis. Shock 2007;27:4-9. (Pubitemid 44968003)
63. Barber RC, Chang LY, Arnoldo BD, Purdue GF, Hunt JL, Horton JW, et al. Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin Med Res 2006;4:250-5. (Pubitemid 46166376)
64. Phan HH, Cho K, Sainz-Lyon KS, Shin S, Greenhalgh DG. CD14-dependent modulation of NF-kB alternative splicing in the lung after burn injury. Gene 2006;371:121-9.
65. Barber RC, Maass DL, White DJ, Chang LYE, Horton JW. Molecular or pharmacologic inhibition of the CD14 signaling pathway protects against burn-related myocardial inflammation and dysfunction. Shock 2008;30:705-13.